The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...

Popular diabetes and weight-loss drugs known as GLP-1s are helping to boost the biopharma sector's return on investment this ...

Wasatch Global Select Fund—Investor Class was down -3.90%, underperforming the benchmark MSCI AC (All Country) World Index, ...

There is a growing opportunity to expand clinical research capacity in Africa, and numerous organisations are contributing to this effort. To name a few: the African Medicines Agency provides ...

A leading U.S.-based drug delivery device company known for its strong global commercial presence recognized this opportunity ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Roche Holding AG (RHHBY), Comcast ...

Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company that provides biotech and small- to mid-sized pharma companies an accelerated path to ...

The global ethoxylates industry size is valued at USD 12.1 billion in 2022 and it is anticipated to achieve a market valuation of USD 12.7 billion in 2023. It is expected to reach a market valuation ...

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take ...

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take ...

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take ...

U.S. investors are set to see a decline in stock-based wealth of a whopping $3T for Q1 2025, according to estimates from BofA ...